English  |  正體中文  |  简体中文  |  總筆數 :2832440  
造訪人次 :  33818563    線上人數 :  1362
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"zi yang"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 1-6 / 6 (共1頁)
1 
每頁顯示[10|25|50]項目

機構 日期 題名 作者
國立成功大學 2023-10-4 Chronic kidney outcomes associated with GLP-1 receptor agonists versus long-acting insulins among type 2 diabetes patients requiring intensive glycemic control: a nationwide cohort study Peng;Zi-Yang;Yang;Chun-Ting;Lin;Wei-Hung;Yao;Wen-Yu;Ou;Huang-Tz;Kuo;Shihchen
國立成功大學 2023-09 Effect of SGLT2 inhibitors versus DPP4 inhibitors on major and non-major osteoporotic fracture risks among general and high-risk type 2 diabetes patients: A nationwide retrospective cohort study Peng;Zi-Yang;Wang;Yao-Tseng;Chang;Chin-Sung;Wu;Chih-Hsing;Ou;Huang-Tz
國立成功大學 2022-12-15 Restricted Mean Survival Time Analysis to Estimate SGLT2i-Associated Heterogeneous Treatment Effects on Primary and Secondary Prevention of Cardiorenal Outcomes in Patients With Type 2 Diabetes in Taiwan Peng;Zi-Yang;Yang;Chun-Ting;Kuo;Shihchen;Wu;Chih-Hsing;Lin;Wei-Hung;Ou;Huang-Tz
國立成功大學 2022-09 Reduced All-Cause Mortality with Bisphosphonates Among Post-Fracture Osteoporosis Patients: A Nationwide Study and Systematic Review Hsu;Yu-Hsuan;Li;Chia-Chun;Liang;Fu-Wen;Peng;Zi-Yang;Chang;Yin-Fan;Hsu;Jason, C.;Ou;Huang-Tz;Wu;Chih-Hsing
國立成功大學 2022-07 Cost-effectiveness of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors among patients with type 2 diabetes with and without established cardiovascular diseases: A model-based simulation analysis using 10-year real-world d Peng;Zi-Yang;Yang;Chun-Ting;Ou;Huang-Tz;Kuo;Shihchen
國立成功大學 2022-03-7 Cardiovascular Benefits With Favorable Renal, Amputation and Hypoglycemic Outcomes of SGLT-2 Inhibitors in Type 2 Diabetes From the Asian Perspective: A Population-Based Cohort Study and Systematic Review Yang;Chun-Ting;Peng;Zi-Yang;Chen;Yi-Chi;Ou;Huang-Tz;Kuo;Shihchen

顯示項目 1-6 / 6 (共1頁)
1 
每頁顯示[10|25|50]項目